StockData
uniQure N.V. logo

uniQure N.V. (QURE) stock

QURENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30224% above fair value
$20.78−1.10 (-5.03%)

Close on Nov 17, 2026Market cap $1.44BP/E –Yield –

uniQure enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

uniQure's enterprise value was $1.34B on Nov 11, 2026, against $1.17B a year earlier. Over the last 5 years it ranged from -$143.51M to $3.51B, with a median of $566.64M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$1.34B+42.4%
2025Dec 31, 2025$942.45M+42.7%
2024Dec 31, 2024$660.22M+237.5%
2023Dec 29, 2023$195.62M-73.0%
2022Dec 30, 2022$723.38M+60.3%
2021Dec 31, 2021$451.38M-66.9%
2020Dec 31, 2020$1.36B-50.6%
2019Dec 31, 2019$2.76B+222.4%
2018Dec 31, 2018$855.43M+97.2%
2017Dec 29, 2017$433.86M–
2016Dec 30, 2016-$66.42M-130.4%
2015Dec 31, 2015$218.50M–

More uniQure figures

See a number that looks wrong?